PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-03

Date Title Company
03-Oct-2024 Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia Yourgene Health
03-Oct-2024 New Sales Contract with a Healthcare Company Celadon Pharmaceuticals Plc
03-Oct-2024 ERRATUM: ReiThera's manufactured Sudan Ebolavirus Vaccine reaches a key milestone with launching of Sabin Vaccine Institute-sponsored Phase 2 Trial in Uganda ReiThera Srl
03-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma
03-Oct-2024 First Clinical Data on Ornithine Transcarbamylase Deficiency Program to be presented at the European Society of Gene & Cell Therapy 31st Annual Meeting 2024 Bloomsbury Genetic Therapies Limited
03-Oct-2024 UK’s Largest Menopause Event, PAUSE Live, Takes Major Step Forward for Womankind PAUSE Live
03-Oct-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Janssen-Cilag International NV
03-Oct-2024 Solmetex(R) Offers Support to Dental Practices Affected by Hurricane Helene AccessWire
03-Oct-2024 Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development AccessWire
03-Oct-2024 Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe AccessWire
03-Oct-2024 Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG
03-Oct-2024 Coulter Partners conducts successful CEO search for Nitinotes Coulter Partners
03-Oct-2024 Lonza Nominates David Meline as Independent Board Member Lonza Group AG
03-Oct-2024 Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance ABIVAX